[
フレーム]
Please make JavaScript on and see this site.
Back
-
Regulations & Services of PMDA
Information about Approved Products in Japan
-
Information for approved products in Japan
-
Development of Drugs, Medical devices, Regenerative medicines and in Vitro diagnostics
Information for approved products in Japan
-
Regulations and services of PMDA
Information for approved products in Japan
Back
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Regulations and Services of PMDA
Information for apporoved products in Japan
-
Reviews and Related Services
Post-marketing Safety Measures
-
Reviews and Related Services
Post-marketing Safety Measures
Regulatory Science/The Science Board/Standard Development
The 4th Subcommittee on Microbiome
Press Release
Date and Time: March 8, 2021 from 2pm to 3:10pm
Given the impact of COVID-19, the conference was held online.
Agenda / List of Handouts
Agenda
- Introduction of Guidance Documents Announced by Foreign Authorities and Outline of Our Study
- Prewriting the Assigned Parts to Members
- Others
List of Handouts
- Document 1 Explanatory Material by Dr. YAMAGUCHI (Chairperson of the Subcommittee)
- Document 2 Outline of Draft Report (Chapter 3 & 5)
- Document 3 Draft Report (Chapter 3 & 5)
- Document 4 Draft Report (Clinical Trials in Immune and Infectious Disease Areas and Non-Immune, FMT)
- Document 5 Draft Report (Non-clinical Trials)